QQQ   425.61 (-0.40%)
AAPL   182.32 (+0.42%)
MSFT   402.18 (-0.15%)
META   468.03 (-0.68%)
GOOGL   142.55 (+1.01%)
AMZN   168.59 (+0.90%)
TSLA   194.77 (+0.52%)
NVDA   674.72 (-2.85%)
NIO   5.97 (+0.17%)
AMD   164.29 (-0.84%)
BABA   75.58 (+3.34%)
T   17.01 (+0.59%)
F   12.15 (-0.82%)
MU   81.49 (+0.97%)
CGC   3.44 (-2.82%)
GE   149.08 (+0.31%)
DIS   107.68 (-1.61%)
AMC   4.57 (-1.93%)
PFE   27.67 (+0.29%)
PYPL   57.48 (-1.96%)
XOM   104.86 (+2.05%)
QQQ   425.61 (-0.40%)
AAPL   182.32 (+0.42%)
MSFT   402.18 (-0.15%)
META   468.03 (-0.68%)
GOOGL   142.55 (+1.01%)
AMZN   168.59 (+0.90%)
TSLA   194.77 (+0.52%)
NVDA   674.72 (-2.85%)
NIO   5.97 (+0.17%)
AMD   164.29 (-0.84%)
BABA   75.58 (+3.34%)
T   17.01 (+0.59%)
F   12.15 (-0.82%)
MU   81.49 (+0.97%)
CGC   3.44 (-2.82%)
GE   149.08 (+0.31%)
DIS   107.68 (-1.61%)
AMC   4.57 (-1.93%)
PFE   27.67 (+0.29%)
PYPL   57.48 (-1.96%)
XOM   104.86 (+2.05%)
QQQ   425.61 (-0.40%)
AAPL   182.32 (+0.42%)
MSFT   402.18 (-0.15%)
META   468.03 (-0.68%)
GOOGL   142.55 (+1.01%)
AMZN   168.59 (+0.90%)
TSLA   194.77 (+0.52%)
NVDA   674.72 (-2.85%)
NIO   5.97 (+0.17%)
AMD   164.29 (-0.84%)
BABA   75.58 (+3.34%)
T   17.01 (+0.59%)
F   12.15 (-0.82%)
MU   81.49 (+0.97%)
CGC   3.44 (-2.82%)
GE   149.08 (+0.31%)
DIS   107.68 (-1.61%)
AMC   4.57 (-1.93%)
PFE   27.67 (+0.29%)
PYPL   57.48 (-1.96%)
XOM   104.86 (+2.05%)
QQQ   425.61 (-0.40%)
AAPL   182.32 (+0.42%)
MSFT   402.18 (-0.15%)
META   468.03 (-0.68%)
GOOGL   142.55 (+1.01%)
AMZN   168.59 (+0.90%)
TSLA   194.77 (+0.52%)
NVDA   674.72 (-2.85%)
NIO   5.97 (+0.17%)
AMD   164.29 (-0.84%)
BABA   75.58 (+3.34%)
T   17.01 (+0.59%)
F   12.15 (-0.82%)
MU   81.49 (+0.97%)
CGC   3.44 (-2.82%)
GE   149.08 (+0.31%)
DIS   107.68 (-1.61%)
AMC   4.57 (-1.93%)
PFE   27.67 (+0.29%)
PYPL   57.48 (-1.96%)
XOM   104.86 (+2.05%)

NeuroBo Pharmaceuticals (NRBO) Short Interest Ratio & Short Volume

$5.82
+0.47 (+8.79%)
(As of 02/21/2024 ET)

NeuroBo Pharmaceuticals Short Interest Data

Current Short Volume
26,600 shares
Previous Short Volume
19,100 shares
Change Vs. Previous Month
+39.27%
Dollar Volume Sold Short
$86,982.00
Short Interest Ratio / Days to Cover
0.0
Last Record Date
January 31, 2024
Outstanding Shares
4,850,000 shares
Float Size
3,200,000 shares
Short Percent of Float
0.83%
Today's Trading Volume
123,318 shares
Average Trading Volume
2,228,280 shares
Today's Volume Vs. Average
6%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling NeuroBo Pharmaceuticals ?

Sign up to receive the latest short interest report for NeuroBo Pharmaceuticals and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

NRBO Short Interest Over Time

NRBO Days to Cover Over Time

NRBO Percentage of Float Shorted Over Time


NeuroBo Pharmaceuticals Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
1/31/202426,600 shares $86,982.00 +39.3%0.8%0 $3.27
1/15/202419,100 shares $64,558.00 +180.9%0.4%0.6 $3.38
12/31/20236,800 shares $25,136.88 +15.3%0.2%0.2 $3.70
12/15/20235,900 shares $23,590.56 -90.1%0.2%0.5 $4.00
11/30/202359,600 shares $26,700.80 -31.8%N/A1 $0.45
11/15/202387,400 shares $37,599.48 -2.7%N/A1.3 $0.43
10/31/202389,800 shares $37,805.80 -29.5%N/A0.8 $0.42
10/15/2023127,400 shares $60,757.06 +4.3%N/A0.8 $0.48
9/30/2023122,200 shares $58,167.20 +11.1%N/A0.5 $0.48
9/15/2023110,000 shares $59,367.00 -20.1%N/A0.3 $0.54
8/31/2023137,700 shares $61,290.27 -48.0%0.8%0.4 $0.45
8/15/2023265,000 shares $163,770.00 +217.4%1.5%0.7 $0.62
7/31/202383,500 shares $42,835.50 -57.9%0.7%0.2 $0.51
7/15/2023198,500 shares $86,645.25 -67.5%1.5%0.5 $0.44
6/30/2023611,400 shares $267,242.94 +224.5%4.6%1.3 $0.44
6/15/2023188,400 shares $93,069.60 -20.6%1.4%0.5 $0.49
5/31/2023237,400 shares $132,944.00 -9.0%1.8%0.6 $0.56
5/15/2023261,000 shares $154,746.90 +15.6%2.0%0.5 $0.59
4/30/2023225,800 shares $144,512.00 +33.9%1.7%0.4 $0.64
4/15/2023168,600 shares $123,078.00 -26.5%2.3%0.2 $0.73
3/31/2023229,300 shares $162,871.79 -13.3%3.1%0.3 $0.71
3/15/2023264,500 shares $177,320.80 +28.1%4.2%0.2 $0.67
2/28/2023206,500 shares $132,160.00 -40.9%3.3%0.1 $0.64
2/15/2023349,400 shares $251,218.60 -46.1%5.6%0.1 $0.72
1/31/2023648,700 shares $512,473.00 +359.7%10.3%0.2 $0.79
1/15/2023141,100 shares $108,618.78 -85.3%2.2%0 $0.77
12/30/2022958,400 shares $687,652.00 -14.4%15.3%0.3 $0.72
12/15/20221,120,000 shares $1.69 million +29.4%N/A0.3 $1.51
11/30/2022865,400 shares $1.25 million -47.6%N/A0.3 $1.45
11/15/20221,650,000 shares $2.34 million +837.0%45.1%0.6 $1.42
10/31/2022176,100 shares $1.35 million +257.2%9.2%0.1 $7.68
10/15/202249,300 shares $628,575.00 -46.8%9.6%0.1 $12.75
9/30/202292,600 shares $1.27 million -12.3%17.9%0.2 $13.69
9/15/2022105,600 shares $2.62 million -34.5%24.7%0.2 $24.82
8/31/2022161,300 shares $51,422.44 -7.5%1.3%0.1 $0.32
8/15/2022174,400 shares $71,172.64 -5.4%1.4%2 $0.41
7/31/2022184,300 shares $77,664.02 -17.7%1.4%1.9 $0.42
7/15/2022223,900 shares $125,406.39 +2.8%1.9%1.9 $0.56
6/30/2022217,900 shares $104,548.42 +17.2%1.9%1.7 $0.48
6/15/2022186,000 shares $74,772.00 -7.4%1.6%1.4 $0.40













NRBO Short Interest - Frequently Asked Questions

What is NeuroBo Pharmaceuticals' current short interest?

Short interest is the volume of NeuroBo Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of January 31st, investors have sold 26,600 shares of NRBO short. 0.83% of NeuroBo Pharmaceuticals' shares are currently sold short. Learn More on NeuroBo Pharmaceuticals' current short interest.

Which institutional investors are shorting NeuroBo Pharmaceuticals?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of NeuroBo Pharmaceuticals: Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

What is a good short interest percentage for NeuroBo Pharmaceuticals?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.83% of NeuroBo Pharmaceuticals' floating shares are currently sold short.

Is NeuroBo Pharmaceuticals' short interest increasing or decreasing?

NeuroBo Pharmaceuticals saw a increase in short interest in January. As of January 31st, there was short interest totaling 26,600 shares, an increase of 39.3% from the previous total of 19,100 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is NeuroBo Pharmaceuticals' float size?

NeuroBo Pharmaceuticals currently has issued a total of 4,850,000 shares. Some of NeuroBo Pharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. NeuroBo Pharmaceuticals currently has a public float of 3,200,000 shares.

How does NeuroBo Pharmaceuticals' short interest compare to its competitors?

0.83% of NeuroBo Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to NeuroBo Pharmaceuticals: Bullfrog AI Holdings, Inc. (27.74%), SELLAS Life Sciences Group, Inc. (9.73%), Oncternal Therapeutics, Inc. (0.94%), CytoMed Therapeutics Limited (0.08%), Kineta, Inc. (0.37%), Forte Biosciences, Inc. (0.14%), Alaunos Therapeutics, Inc. (11.16%), vTv Therapeutics Inc. (10.65%), CalciMedica, Inc. (0.79%), Viracta Therapeutics, Inc. (2.43%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($4.48 billion), General Motors ($3.85 billion), Charter Communications, Inc. ($3.38 billion), Occidental Petroleum Co. ($3.00 billion), Super Micro Computer, Inc. ($2.66 billion), Tractor Supply ($2.37 billion), Coinbase Global, Inc. ($2.25 billion), Moderna, Inc. ($2.11 billion), Royal Caribbean Cruises Ltd. ($2.06 billion), and Floor & Decor Holdings, Inc. ($1.67 billion). View all of the most shorted stocks.

What does it mean to sell short NeuroBo Pharmaceuticals stock?

Short selling NRBO is an investing strategy that aims to generate trading profit from NeuroBo Pharmaceuticals as its price is falling. NRBO shares are trading up $0.47 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against NeuroBo Pharmaceuticals?

A short squeeze for NeuroBo Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of NRBO, which in turn drives the price of the stock up even further.

How often is NeuroBo Pharmaceuticals' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including NRBO, twice per month. The most recent reporting period available is January, 31 2024.



More Short Interest Resources from MarketBeat

This page (NASDAQ:NRBO) was last updated on 2/21/2024 by MarketBeat.com Staff